Harvard engineers develop 'biospleen' device for sepsis treatment; Cognizant acquires TriZetto for $2.7 billion;

News From Around the Web

> Researchers at Harvard's Wyss Institute for Biologically Inspired Engineering have developed a new device inspired by the human spleen that can filter live and dead pathogens from laboratory-tested blood, as well as toxins released from those pathogens. The device could "radically transform" sepsis treatment. Announcement

> IT consulting firm Cognizant announced this morning that it will acquire health IT software vendor TriZetto for $2.7 billion. Announcement

> The New York-based Hospital for Special Surgery recently launched the HSS Innovation Center, the goal of which, according to an announcement, is to identify and support new medical technologies that will improve patient care while lowering costs. Announcement

Provider News

> Fallout over Baltimore Ravens' Ray Rice's assault of his then-fiancee Janay Palmer has renewed the conversation on domestic violence, and how various healthcare providers collaborate on programs to aid victims. Article

Medical Imaging News

> A secondary analysis of the National Lung Screening Trial has found that low-dose lung cancer screening is actually more effective for older high-risk patients than it is for younger ones, according to a study in the Annals of Internal Medicine. The findings should add more ammunition to CT lung cancer screening advocates in the debate on whether Medicare should cover screening for older, at-risk beneficiaries. Article

And Finally... I'd say he's good for the part. Article